Q3 2025 Earnings Call Transcript November 12, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is ...

Increased 5% with management citing ongoing focus on profitable accounts. Technology Platform Development -- Infusion of ...

Some of which may be outside our control and that could cause actual results to differ materially from those expressed or ...

Earlier today, Hyperfine, Inc. released financial results for the quarter ended September 30, 2025. Before we begin, I would ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Q3 2025 Earnings Call Transcript November 12, 2025 uCloudlink Group Inc. misses on earnings expectations. Reported EPS is ...

Management revised projected enrollment completion to the first half of 2026, citing "delays in the activation of the new ...

Across Flagstaff’s three community gardens, residents come together to grow food, share knowledge and build community. From ...